- Home
- PRTA vs CFFN Comparison
PRTA vs CFFN Comparison
Compare PRTA & CFFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- CFFN
- Stock Information
- Founded
- PRTA 2012
- CFFN 1893
- Country
- PRTA Ireland
- CFFN United States
- Employees
- PRTA N/A
- CFFN N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- CFFN Savings Institutions
- Sector
- PRTA Health Care
- CFFN Finance
- Exchange
- PRTA Nasdaq
- CFFN Nasdaq
- Market Cap
- PRTA 809.8M
- CFFN N/A
- IPO Year
- PRTA N/A
- CFFN 1999
- Fundamental
- Price
- PRTA $12.14
- CFFN $5.64
- Analyst Decision
- PRTA Buy
- CFFN Hold
- Analyst Count
- PRTA 9
- CFFN 2
- Target Price
- PRTA $54.57
- CFFN $6.50
- AVG Volume (30 Days)
- PRTA 454.8K
- CFFN 658.8K
- Earning Date
- PRTA 05-07-2025
- CFFN 04-23-2025
- Dividend Yield
- PRTA N/A
- CFFN 6.10%
- EPS Growth
- PRTA N/A
- CFFN N/A
- EPS
- PRTA N/A
- CFFN 0.39
- Revenue
- PRTA $135,157,000.00
- CFFN $181,716,000.00
- Revenue This Year
- PRTA N/A
- CFFN $7.19
- Revenue Next Year
- PRTA $131.75
- CFFN $9.50
- P/E Ratio
- PRTA N/A
- CFFN $14.26
- Revenue Growth
- PRTA 47.92
- CFFN N/A
- 52 Week Low
- PRTA $11.42
- CFFN $4.76
- 52 Week High
- PRTA $25.42
- CFFN $7.20
- Technical
- Relative Strength Index (RSI)
- PRTA 38.46
- CFFN 42.78
- Support Level
- PRTA $11.42
- CFFN $5.52
- Resistance Level
- PRTA $13.52
- CFFN $5.79
- Average True Range (ATR)
- PRTA 0.75
- CFFN 0.13
- MACD
- PRTA -0.12
- CFFN -0.00
- Stochastic Oscillator
- PRTA 24.66
- CFFN 37.50
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).